Laronidase: Side Effects, Uses & Monitoring

Facts extracted from current FDA product labeling for Laronidase. Educational only — not medical advice.

Labeled uses

ALDURAZYME ® is indicated for the treatment of: adult and pediatric patients with Hurler and Hurler-Scheie forms of Mucopolysaccharidosis I (MPS I) and patients with the Scheie form of MPS I who have moderate to severe symptoms.

Source: FDA labeling via NIH DailyMed (set a80ac249…). Not affiliated with FDA or NIH.

Medical disclaimer: Always consult a qualified healthcare professional about any medication.

Ratings summarize government-reported measures — they don't capture your personal needs. Visit the facility, ask about staffing and services, and use CMS checklists. This profile is informational only and is not a recommendation.